FT Options
Latest statistics and disclosures from FT Options's latest quarterly 13F-HR filing:
- Top 5 stock holdings are INCY, GILD, Clovis Oncology, IBB, INSM, and represent 35.42% of FT Options's stock portfolio.
- Added to shares of these 10 stocks: GILD (+$14M), INCY (+$8.8M), INSM (+$5.9M), ABBV (+$5.8M), DBVT (+$5.4M), Zogenix, Time Warner, Aimmune Therapeutics, ALNY, NKE.
- Started 47 new stock positions in MOS, Rockwell Collins, HLF, DXCM, QSR, United Technologies Corporation, Aimmune Therapeutics, HSIC, Tetraphase Pharmaceuticals, Ggp.
- Reduced shares in these 10 stocks: Portola Pharmaceuticals (-$12M), Clovis Oncology (-$7.9M), GIS (-$6.2M), AMGN (-$5.5M), CLX (-$5.4M), , K, , IBB, REGN.
- Sold out of its positions in AK Steel Holding Corporation, A, AMGN, Bank of the Ozarks, BCRX, BKD, CPB, Celgene Corporation, STZ, COST.
- FT Options was a net seller of stock by $-1.6M.
- FT Options has $184M in assets under management (AUM), dropping by -10.35%.
- Central Index Key (CIK): 0001594954
Tip: Access up to 7 years of quarterly data
Positions held by FT Options consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for FT Options
FT Options holds 112 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Incyte Corporation (INCY) | 7.6 | $14M | +167% | 120k | 116.76 |
|
| Gilead Sciences (GILD) | 7.6 | $14M | NEW | 172k | 80.99 |
|
| Clovis Oncology | 7.0 | $13M | -38% | 156k | 82.39 |
|
| iShares NASDAQ Biotechnology Index (IBB) | 6.7 | $12M | -16% | 37k | 333.70 |
|
| Insmed (INSM) | 6.5 | $12M | +97% | 386k | 31.19 |
|
| Gw Pharmaceuticals Plc ads | 6.5 | $12M | +21% | 117k | 101.50 |
|
| Tesaro | 5.1 | $9.3M | +8% | 72k | 129.10 |
|
| Time Warner | 5.0 | $9.2M | +48% | 90k | 102.40 |
|
| Abbvie (ABBV) | 4.1 | $7.6M | +327% | 85k | 88.84 |
|
| General Mills (GIS) | 3.3 | $6.1M | -50% | 119k | 51.80 |
|
| Regeneron Pharmaceuticals (REGN) | 3.2 | $5.9M | -28% | 13k | 447.20 |
|
| Dbv Technologies S A (DBVT) | 3.0 | $5.4M | NEW | 128k | 42.43 |
|
| Kimberly-Clark Corporation (KMB) | 2.8 | $5.2M | +38% | 44k | 117.63 |
|
| Zogenix | 2.5 | $4.6M | NEW | 130k | 35.07 |
|
| Clorox Company (CLX) | 2.1 | $3.9M | -57% | 30k | 132.08 |
|
| Sage Therapeutics (SAGE) | 2.1 | $3.9M | -24% | 64k | 62.23 |
|
| Alibaba Group Holding (BABA) | 1.9 | $3.4M | 20k | 172.73 |
|
|
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $2.9M | +509% | 140k | 20.78 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.5 | $2.7M | +13% | 112k | 24.27 |
|
| Aimmune Therapeutics | 1.5 | $2.7M | NEW | 109k | 24.81 |
|
| Nike (NKE) | 1.1 | $2.1M | NEW | 41k | 51.86 |
|
| DaVita (DVA) | 1.1 | $2.0M | -28% | 35k | 59.37 |
|
| Ptc Therapeutics I (PTCT) | 1.0 | $1.9M | NEW | 92k | 20.04 |
|
| Akebia Therapeutics (AKBA) | 0.9 | $1.7M | +45% | 220k | 7.62 |
|
| La Jolla Pharmaceuticl Com Par | 0.9 | $1.6M | NEW | 45k | 34.87 |
|
| Bristol Myers Squibb (BMY) | 0.8 | $1.5M | +104% | 177k | 8.73 |
|
| Intercept Pharmaceuticals In | 0.8 | $1.5M | NEW | 111k | 13.55 |
|
| Kraft Heinz (KHC) | 0.8 | $1.5M | -59% | 19k | 77.50 |
|
| Kite Pharma | 0.8 | $1.5M | +348% | 114k | 12.84 |
|
| Restaurant Brands Intl Inc Com equity / large cap (QSR) | 0.6 | $1.1M | NEW | 18k | 63.92 |
|
| Aerie Pharmaceuticals | 0.6 | $1.0M | +8% | 21k | 48.62 |
|
| Anheuser-Busch InBev NV (BUD) | 0.5 | $847k | -41% | 7.1k | 119.30 |
|
| Kellogg Company (K) | 0.5 | $819k | -85% | 13k | 62.50 |
|
| Amicus Therapeutics (FOLD) | 0.5 | $826k | +78% | 150k | 5.49 |
|
| Esperion Therapeutics (ESPR) | 0.5 | $833k | -73% | 17k | 50.08 |
|
| Wal-Mart Stores (WMT) | 0.4 | $782k | NEW | 10k | 78.20 |
|
| Uniqure Nv (QURE) | 0.4 | $686k | -51% | 72k | 9.58 |
|
| Hain Celestial (HAIN) | 0.3 | $629k | -58% | 15k | 41.11 |
|
| Dex (DXCM) | 0.3 | $610k | NEW | 13k | 48.80 |
|
| Juno Therapeutics | 0.3 | $599k | NEW | 13k | 45.00 |
|
| Foot Locker (FL) | 0.3 | $582k | NEW | 17k | 35.25 |
|
| Sarepta Therapeutics (SRPT) | 0.3 | $596k | +76% | 92k | 6.46 |
|
| Tetraphase Pharmaceuticals | 0.3 | $594k | NEW | 87k | 6.83 |
|
| Scynexis | 0.3 | $581k | -3% | 241k | 2.41 |
|
| Fibrocell Science | 0.3 | $484k | NEW | 159k | 3.05 |
|
| Newlink Genetics Corporation | 0.2 | $416k | NEW | 41k | 10.19 |
|
| Bluebird Bio (BLUE) | 0.2 | $405k | NEW | 23k | 17.60 |
|
| Intuitive Surgical (ISRG) | 0.2 | $356k | -55% | 4.5k | 79.00 |
|
| Illumina (ILMN) | 0.2 | $350k | 14k | 24.65 |
|
|
| Mosaic (MOS) | 0.2 | $342k | NEW | 16k | 21.44 |
|
| Hershey Company (HSY) | 0.2 | $329k | +25% | 80k | 4.12 |
|
| Puma Biotechnology (PBYI) | 0.2 | $314k | -69% | 25k | 12.34 |
|
| Dermira | 0.2 | $309k | NEW | 112k | 2.77 |
|
| Avexis | 0.2 | $296k | +104% | 43k | 6.89 |
|
| Mondelez Int (MDLZ) | 0.1 | $271k | -7% | 134k | 2.03 |
|
| Vaneck Vectors Gold Miners mutual (GDX) | 0.1 | $269k | NEW | 12k | 22.90 |
|
| Ggp | 0.1 | $241k | NEW | 12k | 20.49 |
|
| Potash Corp. Of Saskatchewan I | 0.1 | $217k | -91% | 11k | 19.21 |
|
| Teva Pharmaceutical Industries (TEVA) | 0.1 | $171k | NEW | 380k | 0.45 |
|
| Paypal Holdings (PYPL) | 0.1 | $174k | -25% | 30k | 5.80 |
|
| Nabriva Therapeutics | 0.1 | $164k | +32% | 20k | 8.20 |
|
| Alexion Pharmaceuticals | 0.1 | $105k | NEW | 15k | 7.20 |
|
| Cal-Maine Foods (CALM) | 0.1 | $105k | NEW | 45k | 2.33 |
|
| Cytokinetics (CYTK) | 0.1 | $108k | NEW | 36k | 2.99 |
|
| Zynerba Pharmaceuticals | 0.1 | $114k | +400% | 63k | 1.82 |
|
| Ionis Pharmaceuticals (IONS) | 0.1 | $112k | NEW | 104k | 1.07 |
|
| Cascadian Therapeutics | 0.1 | $119k | -6% | 119k | 1.00 |
|
| ACADIA Pharmaceuticals (ACAD) | 0.1 | $100k | +13% | 12k | 8.62 |
|
| Firsthand Tech Value (SVVC) | 0.1 | $88k | -45% | 11k | 8.00 |
|
| Chimerix (CMRX) | 0.1 | $99k | +99% | 150k | 0.66 |
|
| Zafgen | 0.1 | $90k | -57% | 26k | 3.51 |
|
| Loxo Oncology | 0.1 | $95k | NEW | 13k | 7.33 |
|
| Axovant Sciences | 0.1 | $95k | +1144% | 528k | 0.18 |
|
| Monsanto Company | 0.0 | $65k | -15% | 21k | 3.04 |
|
| Verizon Communications (VZ) | 0.0 | $77k | +61% | 53k | 1.47 |
|
| Kohl's Corporation (KSS) | 0.0 | $60k | NEW | 18k | 3.43 |
|
| Colgate-Palmolive Company (CL) | 0.0 | $62k | -45% | 61k | 1.02 |
|
| Henry Schein (HSIC) | 0.0 | $61k | NEW | 36k | 1.68 |
|
| Big Lots (BIG) | 0.0 | $52k | NEW | 13k | 3.90 |
|
| Herbalife Ltd Com Stk (HLF) | 0.0 | $47k | NEW | 15k | 3.13 |
|
| Spark Therapeutics | 0.0 | $54k | NEW | 29k | 1.85 |
|
| Inotek Pharmaceuticals | 0.0 | $63k | -87% | 35k | 1.80 |
|
| Zosano Pharma | 0.0 | $49k | 60k | 0.82 |
|
|
| Nordstrom (JWN) | 0.0 | $43k | NEW | 58k | 0.74 |
|
| Rockwell Collins | 0.0 | $44k | NEW | 12k | 3.64 |
|
| United Therapeutics Corporation (UTHR) | 0.0 | $33k | NEW | 11k | 3.08 |
|
| Valeant Pharmaceuticals Int | 0.0 | $40k | -31% | 51k | 0.78 |
|
| EXACT Sciences Corporation (EXAS) | 0.0 | $44k | NEW | 14k | 3.14 |
|
| Metropcs Communications (TMUS) | 0.0 | $34k | NEW | 20k | 1.69 |
|
| Perrigo Company (PRGO) | 0.0 | $29k | NEW | 15k | 1.93 |
|
| Versartis | 0.0 | $31k | NEW | 520k | 0.06 |
|
| Aercap Holdings Nv Ord Cmn (AER) | 0.0 | $16k | NEW | 10k | 1.60 |
|
| Coca-Cola Company (KO) | 0.0 | $17k | -59% | 60k | 0.28 |
|
| Spdr S&p 500 Etf (SPY) | 0.0 | $10k | NEW | 25k | 0.40 |
|
| Kroger (KR) | 0.0 | $15k | +156% | 64k | 0.23 |
|
| Pinnacle Foods Inc De | 0.0 | $18k | 27k | 0.67 |
|
|
| Monster Beverage Corp (MNST) | 0.0 | $10k | NEW | 10k | 1.00 |
|
| Coca Cola European Partners (CCEP) | 0.0 | $19k | 35k | 0.53 |
|
|
| Arena Pharmaceuticals | 0.0 | $14k | NEW | 10k | 1.40 |
|
| Abbott Laboratories (ABT) | 0.0 | $3.0k | -54% | 51k | 0.06 |
|
| Harley-Davidson (HOG) | 0.0 | $3.0k | -12% | 10k | 0.30 |
|
| AstraZeneca (AZN) | 0.0 | $9.0k | -21% | 47k | 0.19 |
|
| Pepsi (PEP) | 0.0 | $7.8k | -52% | 49k | 0.16 |
|
| United Technologies Corporation | 0.0 | $4.1k | NEW | 13k | 0.31 |
|
| Ca | 0.0 | $2.0k | 10k | 0.20 |
|
|
| Rite Aid Corporation | 0.0 | $915.000000 | 31k | 0.03 |
|
|
| Children's Place Retail Stores (PLCE) | 0.0 | $5.8k | NEW | 34k | 0.17 |
|
| Church & Dwight (CHD) | 0.0 | $990.000000 | NEW | 17k | 0.06 |
|
| TransDigm Group Incorporated (TDG) | 0.0 | $5.0k | -31% | 11k | 0.47 |
|
| Otonomy | 0.0 | $6.2k | +39% | 207k | 0.03 |
|
| Dynavax Technologies (DVAX) | 0.0 | $0 | -72% | 51k | 0.00 |
|
| Paratek Pharmaceuticals | 0.0 | $5.4k | NEW | 11k | 0.51 |
|
Past Filings by FT Options
SEC 13F filings are viewable for FT Options going back to 2015
- FT Options 2017 Q3 filed Nov. 13, 2017
- FT Options 2017 Q2 filed Aug. 11, 2017
- FT Options 2017 Q1 filed May 12, 2017
- FT Options 2016 Q4 filed Feb. 10, 2017
- FT Options 2016 Q3 filed Nov. 10, 2016
- FT Options 2016 Q2 filed Aug. 12, 2016
- FT Options 2016 Q1 filed May 9, 2016
- FT Options 2015 Q4 filed Feb. 5, 2016